Montelukast Prescribing at BIDDLESTONE HEALTH GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
924
Total Quantity
25.2K
NHS Cost
£1.2K
vs National Avg
+34.9%
BIDDLESTONE HEALTH GROUP prescribed 924 items of Montelukast over the last 12 months at a cost of £1,249 to the NHS. This is 34.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
76
Jul 2026
80
Jul 2026
78
Jul 2026
80
Jul 2026
80
Jul 2026
80
Jul 2026
71
Jul 2026
88
Jul 2026
87
Jul 2026
68
Jul 2026
72
Jul 2026
64
Prescribing Details
| Total Items | 924 |
|---|---|
| Total Quantity | 25,209 |
| Total NHS Cost | £1,249 |
| Presentations | 4 different forms |
| vs National Average | +34.9% |
Montelukast Prescribing Comparison
| This practice | 924 items |
|---|---|
| National average per practice | 685 items |
| Difference | +34.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.